Restricted accessResearch articleFirst published online 1999-10
Protein Phosphatases 1 and 2A Maintain Endothelial Cells in a Resting State,Limiting the Motility that is Needed for the Morphogenic Process of Angiogenesis
Angiogenesis that is induced by cancers, including those of the head and neck, requires endothelial cells to shift from a nonmotile resting state to an increased level of motility. Using a human micro-vascular endothelial cell line, this study shows the importance of the serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A) in restricting endothelial cell motility. Treatment of endothelial cells with increasing concentrations of the PP1 and PP2A inhibitor okadaic acid resulted in cell rounding and increased motility, which was accompanied by cytoskeletal disorganization involving a loss of filamentous β-tubulin and F-actin. These effects occurred at okadaic acid levels that selectively inhibit PP2A and became more prominent with higher levels that inhibit both PP2A and PP1. This study shows the importance of PP1 and PP2A in maintaining cytoskeletal organization, thereby limiting endothelial cell motility, and suggests that pharmacologic approaches to enhance PP1 and PP2A activities may be useful in preventing key events of the angiogenic process.
Get full access to this article
View all access options for this article.
References
1.
FidlerIJEllisLMThe implications of angiogenesis for the biology and therapy of cancer metastasis. Cell1994;79:185–8.
2.
BernsteinLRLiottaLAMolecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol1994;6:106–13.
3.
FolkmanJ.The role of angiogenesis in tumor growth. Semin Cancer Biol1992;3:65–71.
4.
JacksonCJKnopCJGilesI, et al. VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation. Cell Biol Int1994;18:859–67.
5.
BenefieldJPetruzzelliGJFowlerS, et al. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas. Invasion Metastasis1996;16:291–301.
6.
RaoJYHemstreetGPIHurstRE, et al. Cellular F-actin levels as a marker for cellular transformation: Correlation with bladder cancer risk. Cancer Res1991;51:2762–7.
7.
LePUNguyenTNDrolet-SavoieP, et al. Increased β-actin expression in an invasive Moloney sarcoma virus-transformed MDCK cell variant concentrates to the tips of multiple pseudopodia. Cancer Res1998;58:1631–5.
8.
PokornaEJordanPWO'NeillCH, et al. Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motil Cytoskeleton1994;28:25–33.
9.
HuangTJLeeTTLeeWC, et al. Autophosphorylation-dependent protein kinase phosphorylates Ser25, Ser38, Ser65, Ser71, and Ser411 in vimentin and thereby inhibits cytoskeletal intermediate filament assembly. J Protein Chem1994;13:517–25.
10.
LambNJCFernandezAFeramiscoJR, et al. Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the cAMP-dependent protein kinase. J Cell Biol1989;108:2409–22.
11.
HardieDGHaysteadAJSimATRUse of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol1991;201:469–76.
12.
MaierGDWrightMALozanoY, et al. Regulation of cytoskeletal organization in tumor cells by protein phosphatases 1 and 2A. Int J Cancer1995;61:51–4.
13.
YoungMRProtein phosphatases1 and 2A regulate tumor cell migration, invasion and cytoskeletal organization. Adv Exp Med Biol1997;407:311–8.
14.
YoungMRIYoungMELozanoY, et al. Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells. Invasion Metastasis1992;12:253–63.
15.
AdesEWCandalFJSwerlickRA, et al. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol1992;99:683–90.
16.
YoungMRIYoungMELozanoY, et al. Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones. Int J Cancer1991;49:150–5.
17.
YoungMRIOkadaFTadaM, et al. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior. Invasion Metastasis1991;11:48–57.
18.
CohenP.Classification of protein-serine/threonine phosphatases: Identification and quantitation in cell extracts. Methods Enzymol1991;201:389–427.
19.
YoungMRILozanoYDjordjevicA, et al. Protein phosphatases limit tumor motility. Int J Cancer1993;54:1036–41.
20.
MeisingerJPatelSVellodyK, et al. Protein phosphatase-2A association with microtubules and its role in restricting the invasiveness of human head and neck squamous cell carcinoma cells. Cancer Lett1997;111:87–95.
21.
MetzRVellodyKPatelS, et al. Vitamin D3 and ceramide reduce the invasion of tumor cells through extracellular matrix components by elevating protein phosphatase-2A. Invasion Metastasis1997;16:280–90.
22.
HosoyaNMitsuiMYazamaF, et al. Changes in the cytoskeletal structure of cultured smooth muscle cells induced by calyculin-A. J Cell Sci1993;105:883–90.
23.
KreienbuhlPKellerHNiggliV.Protein phosphatase inhibitors okadaic acid and calyculin A alter cell shape and F-actin distribution and inhibit stimulus-dependent increases in cytoskeletal actin of human neutrophils. Blood1992;80:2911–9.
24.
LeeW-CYuJ-SYangS-D, et al. Reversible hyperphosphorylation and reorganization of vimentin intermediate filaments by okadaic acid in 9L brain tumor cells. J Cell Biochem1992;49:378–93.
25.
ShinokiNSakonMKambayashiJ, et al. Involvement of protein phosphatase-1 in cytoskeletal organization of cultured endothelial cells. J Cell Biochem1995;59:368–75.
